Literature DB >> 7719415

Evaluation of portal circulation through the superior mesenteric vein with an enteric capsule of [123I]iodoamphetamine.

S Shiomi1, T Kuroki, Y Miyazawa, T Ueda, T Takeda, S Nishiguchi, S Nakajima, K Kobayashi, H Ochi.   

Abstract

We report a method by which the contribution of the superior mesenteric vein to the portal blood flow can be evaluated noninvasively. An enteric-coated capsule containing [123I]iodoamphetamine is given by mouth 3h before the examination. The data obtained are treated by computer to calculate the portal shunt index (SI) through the superior mesenteric vein. The SI was higher for more severe liver disorders, Increasing in the order of chronic persistent hepatitis, chronic aggressive hepatitis, and cirrhosis. The SI was higher in cirrhotic patients than in chronic hepatitis patients or healthy volunteers (both, P < 0.0001). The SI was higher in cirrhotic patients with esophageal varices than in such patients without varices (P < 0.05). The SI was higher in cirrhotic patients with ascites than in such patients without ascites (P < 0.001). The SI was higher in cirrhotic patients with encephalopathy than in those without encephalopathy (P < 0.01). Correlation was significant between the SI and classical indicators of functional reserve. This method is clinically useful.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7719415     DOI: 10.1007/bf01211375

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  27 in total

1.  Flow of portal and hepatic blood in normal and cirrhotic liver.

Authors:  T NAKAMURA; S NAKAMURA; T KANEKO
Journal:  Nature       Date:  1961-05-27       Impact factor: 49.962

2.  Percutaneous transhepatic catheterization of the portal vein for the study of portal hemodynamics and shunts. A preliminary report.

Authors:  K Okuda; K Suzuki; H Musha; N Arimuzu
Journal:  Gastroenterology       Date:  1977-08       Impact factor: 22.682

3.  Per-rectal portal scintigraphy: comparison between technetium-99m, thallium-201, and iodine-123-HIPDM.

Authors:  D Urbain; O Jeghers; H R Ham
Journal:  J Nucl Med       Date:  1988-12       Impact factor: 10.057

4.  [Biodistribution of N-isopropyl-p-iodoamphetamine].

Authors:  H Hoshi; S Jinnouchi; K Watanabe; T Ueda; T Yamaguchi
Journal:  Nihon Igaku Hoshasen Gakkai Zasshi       Date:  1987-03-25

5.  Biodistribution and dosimetry of N-isopropyl-p-[123I]iodoamphetamine in the primate.

Authors:  B L Holman; R E Zimmerman; J R Schapiro; M L Kaplan; A G Jones; T C Hill
Journal:  J Nucl Med       Date:  1983-10       Impact factor: 10.057

6.  Acute and chronic hepatitis revisited. Review by an international group.

Authors: 
Journal:  Lancet       Date:  1977-10-29       Impact factor: 79.321

7.  Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics.

Authors:  C Infante-Rivard; S Esnaola; J P Villeneuve
Journal:  Hepatology       Date:  1987 Jul-Aug       Impact factor: 17.425

8.  Superior mesenteric angiography and blood flow measurement following intra-arterial injection of prostaglandin E1.

Authors:  R A Clark; D P Colley; E D Jacobson; R Herman; G Tyler; D Stahl
Journal:  Radiology       Date:  1980-02       Impact factor: 11.105

9.  Significance of blood flow in the inferior and superior mesenteric veins for the formation of oesophageal varices.

Authors:  S Shiomi; T Kuroki; T Ueda; N Ikeoka; S Nishiguchi; S Nakajima; K Kobayashi; T Monna; H Ochi
Journal:  J Gastroenterol Hepatol       Date:  1991 Mar-Apr       Impact factor: 4.029

10.  Hepatography patterns following rectal administration of radioiodine as seen in chronic liver disease and other liver disorders.

Authors:  M Steinberg; J W Rasmussen
Journal:  Scand J Gastroenterol       Date:  1974       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.